Explores NK cell activation via endothelium, suggesting new therapeutic approaches.
Introduction Natural killer (NK) cells circulate in the blood in a poised but inactive state and can be further primed by activating signals to acquire enhanced cytotoxicity and secretion of pro-inflammatory cytokines such as IFN-γ, and TNF-α. We hypothesize that NK cells can be primed by migration through endothelial cells (ECs) as they enter graft or tumor tissue. Methods Nk cell isolation, Flow cytometry. Trans-endothelial migation assay. Results We observed that isolated human blood NK cells will undergo trans-endothelial migration (TEM) through IL-1β-activated but not resting EC monolayers over 60 minutes. Human peripheral blood NK cells showed a rapid rise of P-STAT5 in 20-30 minutes and elevated synthesis of TNF-α and Granzyme B after 4-5 days of coculture. IL-15-induced increases of P-STAT5 was inhibited by an anti—IL-15 antibody. Furthermore, we are exploring whether the increased TNF-α and IFN-γ synthesis is inhibited by a pharmacological blocker of HuR binding to their mRNAs. Conclusion Elucidating key molecular interactions at the endothelial interface that govern NK cell behavior has potential implications for therapeutic modulation.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: